Cargando…
CT-Based Radiomics Analysis to Predict Malignancy in Patients with Intraductal Papillary Mucinous Neoplasm (IPMN) of the Pancreas
SIMPLE SUMMARY: The management of intraductal papillary mucinous neoplasms of the pancreas (IPMN) remains controversial due to the relatively high rate of unnecessary surgery for low grade dysplasia (LGD) despite the last international recommendations. The aim of our retrospective study was to asses...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7690711/ https://www.ncbi.nlm.nih.gov/pubmed/33114028 http://dx.doi.org/10.3390/cancers12113089 |
_version_ | 1783614130772508672 |
---|---|
author | Tobaly, David Santinha, Joao Sartoris, Riccardo Dioguardi Burgio, Marco Matos, Celso Cros, Jérôme Couvelard, Anne Rebours, Vinciane Sauvanet, Alain Ronot, Maxime Papanikolaou, Nikolaos Vilgrain, Valérie |
author_facet | Tobaly, David Santinha, Joao Sartoris, Riccardo Dioguardi Burgio, Marco Matos, Celso Cros, Jérôme Couvelard, Anne Rebours, Vinciane Sauvanet, Alain Ronot, Maxime Papanikolaou, Nikolaos Vilgrain, Valérie |
author_sort | Tobaly, David |
collection | PubMed |
description | SIMPLE SUMMARY: The management of intraductal papillary mucinous neoplasms of the pancreas (IPMN) remains controversial due to the relatively high rate of unnecessary surgery for low grade dysplasia (LGD) despite the last international recommendations. The aim of our retrospective study was to assess the performance of radiomic analysis on CT in differentiating benign from malignant IPMN. We confirmed in a training cohort (296 patients) and a validation cohort (112 patients) that a total of 85 radiomics features provided valuable additional and independent information for discriminating benign from malignant tumors in the training cohort with an area under the ROC curve (AUC) of 0.84 and an external validation with an AUC of 0.71 with higher performance when implementing clinical variables leading to the indication to surgery. We have demonstrated the capabilities of radiomics models comprising LGD versus high-grade dysplasia (HGD) versus invasive, LGD and HGD, HGD and invasive. ABSTRACT: To assess the performance of CT-based radiomics analysis in differentiating benign from malignant intraductal papillary mucinous neoplasms of the pancreas (IPMN), preoperative scans of 408 resected patients with IPMN were retrospectively analyzed. IPMNs were classified as benign (low-grade dysplasia, n = 181), or malignant (high grade, n = 128, and invasive, n = 99). Clinicobiological data were reported. Patients were divided into a training cohort (TC) of 296 patients and an external validation cohort (EVC) of 112 patients. After semi-automatic tumor segmentation, PyRadiomics was used to extract radiomics features. A multivariate model was developed using a logistic regression approach. In the training cohort, 85/107 radiomics features were significantly different between patients with benign and malignant IPMNs. Unsupervised clustering analysis revealed four distinct clusters of patients with similar radiomics features patterns with malignancy as the most significant association. The multivariate model differentiated benign from malignant tumors in TC with an area under the ROC curve (AUC) of 0.84, sensitivity (Se) of 0.82, specificity (Spe) of 0.74, and in EVC with an AUC of 0.71, Se of 0.69, Spe of 0.57. This large study confirms the high diagnostic performance of preoperative CT-based radiomics analysis to differentiate between benign from malignant IPMNs. |
format | Online Article Text |
id | pubmed-7690711 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-76907112020-11-27 CT-Based Radiomics Analysis to Predict Malignancy in Patients with Intraductal Papillary Mucinous Neoplasm (IPMN) of the Pancreas Tobaly, David Santinha, Joao Sartoris, Riccardo Dioguardi Burgio, Marco Matos, Celso Cros, Jérôme Couvelard, Anne Rebours, Vinciane Sauvanet, Alain Ronot, Maxime Papanikolaou, Nikolaos Vilgrain, Valérie Cancers (Basel) Article SIMPLE SUMMARY: The management of intraductal papillary mucinous neoplasms of the pancreas (IPMN) remains controversial due to the relatively high rate of unnecessary surgery for low grade dysplasia (LGD) despite the last international recommendations. The aim of our retrospective study was to assess the performance of radiomic analysis on CT in differentiating benign from malignant IPMN. We confirmed in a training cohort (296 patients) and a validation cohort (112 patients) that a total of 85 radiomics features provided valuable additional and independent information for discriminating benign from malignant tumors in the training cohort with an area under the ROC curve (AUC) of 0.84 and an external validation with an AUC of 0.71 with higher performance when implementing clinical variables leading to the indication to surgery. We have demonstrated the capabilities of radiomics models comprising LGD versus high-grade dysplasia (HGD) versus invasive, LGD and HGD, HGD and invasive. ABSTRACT: To assess the performance of CT-based radiomics analysis in differentiating benign from malignant intraductal papillary mucinous neoplasms of the pancreas (IPMN), preoperative scans of 408 resected patients with IPMN were retrospectively analyzed. IPMNs were classified as benign (low-grade dysplasia, n = 181), or malignant (high grade, n = 128, and invasive, n = 99). Clinicobiological data were reported. Patients were divided into a training cohort (TC) of 296 patients and an external validation cohort (EVC) of 112 patients. After semi-automatic tumor segmentation, PyRadiomics was used to extract radiomics features. A multivariate model was developed using a logistic regression approach. In the training cohort, 85/107 radiomics features were significantly different between patients with benign and malignant IPMNs. Unsupervised clustering analysis revealed four distinct clusters of patients with similar radiomics features patterns with malignancy as the most significant association. The multivariate model differentiated benign from malignant tumors in TC with an area under the ROC curve (AUC) of 0.84, sensitivity (Se) of 0.82, specificity (Spe) of 0.74, and in EVC with an AUC of 0.71, Se of 0.69, Spe of 0.57. This large study confirms the high diagnostic performance of preoperative CT-based radiomics analysis to differentiate between benign from malignant IPMNs. MDPI 2020-10-23 /pmc/articles/PMC7690711/ /pubmed/33114028 http://dx.doi.org/10.3390/cancers12113089 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Tobaly, David Santinha, Joao Sartoris, Riccardo Dioguardi Burgio, Marco Matos, Celso Cros, Jérôme Couvelard, Anne Rebours, Vinciane Sauvanet, Alain Ronot, Maxime Papanikolaou, Nikolaos Vilgrain, Valérie CT-Based Radiomics Analysis to Predict Malignancy in Patients with Intraductal Papillary Mucinous Neoplasm (IPMN) of the Pancreas |
title | CT-Based Radiomics Analysis to Predict Malignancy in Patients with Intraductal Papillary Mucinous Neoplasm (IPMN) of the Pancreas |
title_full | CT-Based Radiomics Analysis to Predict Malignancy in Patients with Intraductal Papillary Mucinous Neoplasm (IPMN) of the Pancreas |
title_fullStr | CT-Based Radiomics Analysis to Predict Malignancy in Patients with Intraductal Papillary Mucinous Neoplasm (IPMN) of the Pancreas |
title_full_unstemmed | CT-Based Radiomics Analysis to Predict Malignancy in Patients with Intraductal Papillary Mucinous Neoplasm (IPMN) of the Pancreas |
title_short | CT-Based Radiomics Analysis to Predict Malignancy in Patients with Intraductal Papillary Mucinous Neoplasm (IPMN) of the Pancreas |
title_sort | ct-based radiomics analysis to predict malignancy in patients with intraductal papillary mucinous neoplasm (ipmn) of the pancreas |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7690711/ https://www.ncbi.nlm.nih.gov/pubmed/33114028 http://dx.doi.org/10.3390/cancers12113089 |
work_keys_str_mv | AT tobalydavid ctbasedradiomicsanalysistopredictmalignancyinpatientswithintraductalpapillarymucinousneoplasmipmnofthepancreas AT santinhajoao ctbasedradiomicsanalysistopredictmalignancyinpatientswithintraductalpapillarymucinousneoplasmipmnofthepancreas AT sartorisriccardo ctbasedradiomicsanalysistopredictmalignancyinpatientswithintraductalpapillarymucinousneoplasmipmnofthepancreas AT dioguardiburgiomarco ctbasedradiomicsanalysistopredictmalignancyinpatientswithintraductalpapillarymucinousneoplasmipmnofthepancreas AT matoscelso ctbasedradiomicsanalysistopredictmalignancyinpatientswithintraductalpapillarymucinousneoplasmipmnofthepancreas AT crosjerome ctbasedradiomicsanalysistopredictmalignancyinpatientswithintraductalpapillarymucinousneoplasmipmnofthepancreas AT couvelardanne ctbasedradiomicsanalysistopredictmalignancyinpatientswithintraductalpapillarymucinousneoplasmipmnofthepancreas AT reboursvinciane ctbasedradiomicsanalysistopredictmalignancyinpatientswithintraductalpapillarymucinousneoplasmipmnofthepancreas AT sauvanetalain ctbasedradiomicsanalysistopredictmalignancyinpatientswithintraductalpapillarymucinousneoplasmipmnofthepancreas AT ronotmaxime ctbasedradiomicsanalysistopredictmalignancyinpatientswithintraductalpapillarymucinousneoplasmipmnofthepancreas AT papanikolaounikolaos ctbasedradiomicsanalysistopredictmalignancyinpatientswithintraductalpapillarymucinousneoplasmipmnofthepancreas AT vilgrainvalerie ctbasedradiomicsanalysistopredictmalignancyinpatientswithintraductalpapillarymucinousneoplasmipmnofthepancreas |